Evidence map›Paper›PMID 25748048›Full record

ArticleCellular signalling2015

Association of p75(NTR) and α9β1 integrin modulates NGF-dependent cellular responses.

Erin M Ventresca, Shimon Lecht, Piotr Jakubowski, Rachel A Chiaverelli, Michael Weaver, Luis Del Valle, Keren Ettinger, Galit Gincberg, Avi Priel, Alex Braiman and 3 more

Abstract read
In one paragraph

Article in Cellular signalling, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cell surface receptors for CCN proteins.Journal of cell communication and signaling · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Erin M VentrescaCoE Department of Bioengineering, Temple University, Philadelphia, PA, USA.
Shimon LechtCoE Department of Bioengineering, Temple University, Philadelphia, PA, USA.
Piotr JakubowskiCoE Department of Bioengineering, Temple University, Philadelphia, PA, USA.
Rachel A ChiaverelliCoE Department of Bioengineering, Temple University, Philadelphia, PA, USA.
Michael WeaverDepartment of Neurosurgery, Temple University Hospital, Philadelphia, PA, USA.
Luis Del ValleDepartment of Medicine and Pathology, Stanley Scott Cancer Center, Louisiana State University, New Orleans, LA, USA.
Keren EttingerSchool of Pharmacy, Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel.
Galit GincbergSchool of Pharmacy, Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel.
Avi PrielSchool of Pharmacy, Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel.
Alex BraimanThe Shraga Segal Department of Microbiology, Immunology and Genetics, The Faculty of Health Science, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Philip LazaroviciCoE Department of Bioengineering, Temple University, Philadelphia, PA, USA; School of Pharmacy, Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel.
Peter I LelkesCoE Department of Bioengineering, Temple University, Philadelphia, PA, USA.
Cezary MarcinkiewiczCoE Department of Bioengineering, Temple University, Philadelphia, PA, USA. Electronic address: cmarcink@temple.edu.
Temple University · USHebrew University of Jerusalem · ILBen-Gurion University of the Negev · ILLouisiana State University · USTemple University Hospital · US

Funding

Interaction of thrombospondin-1 with alpha9beta1 integrin in glioma angiogenesisR01CA133262 · NCI · TEMPLE UNIV OF THE COMMONWEALTH · PI MARCINKIEWICZ, CEZARY · 2009 to 2012
$1.2M
NCI NIH HHS R01 CA133262NCI NIH HHS R01CA133262
6 · The paper itself

Abstract

Direct interaction of α9β1 integrin with nerve growth factor (NGF) has been previously reported to induce pro-proliferative and pro-survival activities of non-neuronal cells. We investigated participation of p75(NTR) in α9β1 integrin-dependent cellular response to NGF stimulation. Using selective transfection of glioma cell lines with these receptors, we showed a strong, cation-independent association of α9 integrin subunit with p75(NTR) on the cellular membrane by selective immunoprecipitation experiments. The presence of the α9/p75(NTR) complex increases NGF-dependent cell adhesion, proliferation and migration. Other integrin subunits including β1 were not found in complex with p75(NTR). FRET analysis indicated that p75(NTR) and α9 integrin subunit are not closely associated through their cytoplasmic domains, most probably because of the molecular interference with other cytoplasmic proteins such as paxillin. Interaction of α9β1 integrin with another ligand, VCAM-1 was not modulated by the p75(NTR). α9/p75(NTR) complex elevated NGF-dependent activation of MAPK Erk1/2 arty for integrin that may create active complexes with other types of receptors belonging to the TNF superfamily.

Indexed as

AnimalsCell AdhesionCell Line, TumorCell ProliferationFluorescence Resonance Energy TransferHEK293 CellsHumansImmunohistochemistryIntegrinsMiceMicroscopy, ConfocalMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Nerve Growth FactorNerve Tissue ProteinsPaxillinintegrin alpha 9 beta 1IntegrinsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Nerve Growth FactorNerve Tissue ProteinsNGFR protein, humanPaxillinReceptors, Nerve Growth FactorReceptor, trkAVascular Cell Adhesion Molecule-1Cell adhesionCell signalingIntegrin α9β1p75(NTR)Receptor complex

Identifiers

PMID25748048
PMCPMC4409011
OpenAlexW2503601304

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.